Method to inhibit cell growth using oligonucleotides
AssigneeTrustees of Boston University
InventorsBarbara A. Gilchrest, Mark S. Eller
Life of this patent
Estimating the term…
Loading patent…
AssigneeTrustees of Boston University
InventorsBarbara A. Gilchrest, Mark S. Eller
Estimating the term…
Described are methods for treating hyperproliferative disorders, including cancers, by administering to the affected mammal (e.g., human) an effective amount of a composition comprising one or more oligonucleotides which share at least 33% but less than 100% nucleotide sequence identity with the human telomere overhang repeat. Methods of treatment or prevention of hyperproliferative diseases or pre-cancerous conditions affecting epithelial cells, such as psoriasis, atopic dermatitis, or hyperproliferative diseases of other epithelia and methods for reducing photoaging, or oxidative stress or for prophylaxis against or reduction in the likelihood of the development of skin cancer, are also disclosed. The compositions and methods are also useful for treating other cancers, such as for example pancreatic cancer and eradicating cancer stem cells.
A composition comprising oligonucleotide GGTTGGTTGGTTGGTT (SEQ ID NO:
A method of treating a pancreatic cancer in a mammal, the method comprising administering to the mammal an effective amount of a composition comprising oligonucleotide GGTTGGTTGGTTGGTT (SEQ ID NO:
A method for inhibiting growth of cancer stem cells in a human, comprising administering to the human an effective amount of a composition comprising oligonucleotide GGTTGGTTGGTTGGTT (SEQ ID NO:
A method of inducing apoptosis in a cancer stem cell, said method comprising administering to the cancer stem cell an effective amount of a composition comprising oligonucleotide GGTTGGTTGGTTGGTT (SEQ ID NO:
Dependencies are inferred from the claim text.